Takeda To Press On With Core R&D Strategy Post-Shire

Takeda continues to pursue the transformation of its R&D activities, which has already led to expansion of the pipeline, but will continue with core strategies including partnering even after the huge Shire acquisition.

Takeda
TAKEDA TO HOLD R&D COURSE • Source: Takeda

Just over two years into its five-year effort to fundamentally transform its R&D activities, Takeda Pharmaceutical Co. Ltd. says the initiative has led to a more focused approach and an enlarged pipeline, fueled by an open approach to partnering.

With a global emphasis on oncology, gastroenterology, neuroscience and vaccines, the company's drug discovery units have been halved over the...

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Japan

More from Focus On Asia